99 related articles for article (PubMed ID: 4114679)
21. [Preclinical pharmacologic evaluation of bleomycin A6].
Lin FT
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):257-9. PubMed ID: 2483136
[TBL] [Abstract][Full Text] [Related]
22. Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung.
Daly HE; Baecher-Allan CM; Barth RK; D'Angio CT; Finkelstein JN
Toxicol Appl Pharmacol; 1997 Feb; 142(2):303-10. PubMed ID: 9070353
[TBL] [Abstract][Full Text] [Related]
23. Effects of bleomycin and Staphylococcus protein-A on lungs of mice.
Sahu AP; Lal K
Indian J Exp Biol; 1995 Oct; 33(10):734-8. PubMed ID: 8575803
[TBL] [Abstract][Full Text] [Related]
24. Bleomycin lung toxicity: who are the patients with increased risk?
Azambuja E; Fleck JF; Batista RG; Menna Barreto SS
Pulm Pharmacol Ther; 2005; 18(5):363-6. PubMed ID: 15939315
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury.
Suntres ZE; Shek PN
Biomed Environ Sci; 1997 Mar; 10(1):47-59. PubMed ID: 9099426
[TBL] [Abstract][Full Text] [Related]
26. [Effects of granulocyte colony-stimulating factor on experimental bleomycin-induced pulmonary fibrosis].
Skurikhin EG; Andreeva TV; Khmelevskaia ES; Ermolaeva LA; Pershina OV; Ermakova NN; Stepanova IE; Reztsova AM; Krupin VA; Gol'dberg VE; Reĭkhart DV; Dygaĭ AM
Eksp Klin Farmakol; 2012; 75(1):30-3. PubMed ID: 22442961
[TBL] [Abstract][Full Text] [Related]
27. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
28. A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice.
Chen Y; Wang X; Weng D; Tian L; Lv L; Tao S; Chen J
Exp Toxicol Pathol; 2009 Jan; 61(1):59-65. PubMed ID: 18579356
[TBL] [Abstract][Full Text] [Related]
29. Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis.
Schmidt R; Ruppert C; Markart P; Lübke N; Ermert L; Weissmann N; Breithecker A; Ermert M; Seeger W; Günther A
Toxicol Appl Pharmacol; 2004 Mar; 195(2):218-31. PubMed ID: 14998687
[TBL] [Abstract][Full Text] [Related]
30. Bleomycin sensitivity of mice expressing dominant-negative p53 in the lung epithelium.
Ghosh S; Mendoza T; Ortiz LA; Hoyle GW; Fermin CD; Brody AR; Friedman M; Morris GF
Am J Respir Crit Care Med; 2002 Sep; 166(6):890-7. PubMed ID: 12231503
[TBL] [Abstract][Full Text] [Related]
31. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
[TBL] [Abstract][Full Text] [Related]
32. Effects of dimethyl sulfoxide (DMSO) on bleomycin-induced pulmonary fibrosis.
Pepin JM; Langner RO
Biochem Pharmacol; 1985 Jul; 34(13):2386-9. PubMed ID: 2409982
[No Abstract] [Full Text] [Related]
33. Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats.
Cross CE; Warren D; Gerriets JE; Wilson DW; Halliwell B; Last JA
J Lab Clin Med; 1985 Oct; 106(4):433-8. PubMed ID: 2413151
[TBL] [Abstract][Full Text] [Related]
34. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
[TBL] [Abstract][Full Text] [Related]
35. Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients.
Yagoda A; Mukherji B; Young C; Etcubanas E; Lamonte C; Smith JR; Tan CT; Krakoff IH
Ann Intern Med; 1972 Dec; 77(6):861-70. PubMed ID: 4118759
[No Abstract] [Full Text] [Related]
36. Toxicological studies on (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic. Its subacute toxicity in male beagle dogs.
Kurebe M; Yokota M; Chesterman H; Massey JE; Gopinath C; Heywood R
Jpn J Antibiot; 1986 Feb; 39(2):387-402. PubMed ID: 3712750
[No Abstract] [Full Text] [Related]
37. Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice.
Ekimoto H; Takada K; Takahashi K; Matsuda A; Takita T; Umezawa H
J Antibiot (Tokyo); 1984 Jun; 37(6):659-63. PubMed ID: 6204963
[TBL] [Abstract][Full Text] [Related]
38. The Protective Effect of Naringin against Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats.
Turgut NH; Kara H; Elagoz S; Deveci K; Gungor H; Arslanbas E
Pulm Med; 2016; 2016():7601393. PubMed ID: 26977316
[TBL] [Abstract][Full Text] [Related]
39. [Complement determination and paper electrophoretic studies of the rat serum in Masugi nephritis].
Protsch G
Acta Biol Med Ger; 1967; 18(2):251-7. PubMed ID: 5586806
[No Abstract] [Full Text] [Related]
40. Toxicological studies on (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic. Its subacute toxicity and recovery study in beagle dogs.
Kurebe M; Yokota M; Chesterman H; Massey JE; Gopinath C
Jpn J Antibiot; 1986 Feb; 39(2):351-86. PubMed ID: 3712749
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
